| INTRODUCTION
Carcinoembryonic antigen (CEA) is a highly glycosylated cell surface glycoprotein and a member of the immunoglobulin supergene family of intercellular adhesion molecules. 1 Previous studies support the broad use of CEA as a tumor marker because it is expressed at greatly increased levels in adenocarcinomas, particularly in colorectal cancer and cancers of other organs including the pancreas, lung, prostate, ovary, and breast. [2] [3] [4] [5] In addition, serum CEA levels may be modestly increased in several non-neoplastic conditions such as aging, renal, and hepatic insufficiency, and may also be increased in smokers. 2, 3, 6 CEA elevation has been identified in hypothyroidism and chronic obstructive pulmonary disease, 7, 8 although at levels not exceeding 10 ng/mL. 6 Furthermore, recent data have suggested that elevated serum CEA levels are associated with carotid atherosclerosis, type 2 diabetes, insulin resistance, and metabolic syndrome, all of which are conditions associated with oxidative stress and chronic low-grade inflammation.
9-12
Leukocyte count is a simple, easy to obtain, and economic marker of inflammation in clinical practice. 13 In addition to serving as a marker of infection and inflammation, leukocyte count has recently become a useful predictor of certain diseases. 14 Higher leukocyte counts, even within a normal range, are associated with cardiovascular disease (CVD), type 2 diabetes, and metabolic syndrome. [15] [16] [17] Numerous in vitro and in vivo studies have shown that some CEA-related cell adhesion molecules (CEACAMs) that interact with CEA are expressed on neutrophils and regulate neutrophil activation. 18 Serum CEA is routinely checked at health check-up centers in many countries to detect malignancy. Although slight elevations in CEA are commonly observed in apparently healthy persons, potential associations between CEA and chronic low-grade inflammation have yet to be documented. In addition, no studies to date have examined the relationship between serum CEA and leukocyte count in a large, population-based study.
The present study was grounded in the hypothesis that CEA levels may be associated with elevated leukocyte counts in states of chronic low-grade inflammation.
| MATERIALS AND METHODS

| Study participants
We retrospectively reviewed the medical records of 20 618 par- were included in our final analysis after applying the exclusion criteria.
| Data collection
Body mass and height were measured to the nearest 0. 
| Statistical analysis
Baseline clinical characteristics were presented as the mean and standard deviation (SD) for continuous variables, and numbers and percentages for categorical variables.
To assess the association between leukocyte counts and contin- simple and partial correlation analysis was conducted after adjusting for age, sex, and BMI. For categorical variables (sex, cigarette smoking, alcohol ingestion, physical activity, diabetes mellitus and antiinflammatory drugs), the mean values (SD) of leukocytes and mean values (SE) leukocytes adjusting for age, sex, and BMI were calculated and compared using independent t-test and analysis of covariance (ANCOVA), respectively.
Participants were categorized into tertiles based on serum CEA levels as follows: T1≤1.1; 1.1 < T2≤1.9; 1.9<T3≤10 μg/L. ANCOVA and Bonferroni post-hoc test was used to compare leukocyte counts among the three serum CEA groups after adjusting for age, sex, BMI, SBP, total cholesterol, triglyceride, HDL-cholesterol, cigarette smoking, physical activity, and diabetes mellitus. Stepwise-method multiple linear regression analyses were used to evaluate the independent association between serum CEA level and leukocyte counts after adjusting for age, sex, BMI, SBP, DBP, total cholesterol, triglyceride, HDL-cholesterol, cigarette smoking, alcohol ingestion, physical activity, diabetes mellitus, and anti-inflammatory drugs. After performing these analyses, age, sex, BMI, SBP, total cholesterol, triglyceride, HDLcholesterol, cigarette smoking, physical activity, and diabetes mellitus T A B L E 2 Correlation coefficients (r) and mean leukocyte values±SD or SE between leukocyte counts and various variables 
| RESULTS
The demographic and clinical characteristics of the study population of 19 834 subjects (10 394 men and 9440 women) are presented in CEA and leukocyte counts both in unadjusted and adjusted models (r=.150; P <.001 and r=.107; P <.001) ( Table 2 ). Leukocyte counts were also significantly correlated with BMI, SBP, DBP, hs CRP, fasting plasma glucose, total cholesterol, triglyceride, and HDL-cholesterol.
Leukocyte counts were significantly higher in subjects who currently smoked, did not exercise, and had diabetes mellitus after adjusting for age, sex, and BMI. After adjusting for confounding factors, the higher tertile serum CEA group had significantly higher leukocyte counts ( Figure 1 ). Independent association of serum CEA levels with leukocyte count was assessed using multivariable adjusted models generated from stepwise-method multiple linear regression analyses (Table 3) . Serum CEA was identified as a significant independent variable associated with leukocyte count (β=0.131; P <.001). In addition, the significant association between serum CEA level with leukocyte count persisted in the enter-method multiple linear regression analysis after adjusting for age, sex, BMI, SBP, DBP, total cholesterol, triglyceride, HDL-cholesterol, current smoking, alcohol ingestion, physical activity, diabetes mellitus, and anti-inflammatory drug ( Table 3 ). The 
| DISCUSSION
In the present study, we confirmed that serum CEA levels were associated with leukocyte counts in a large population-based crosssectional study. Serum CEA levels were independently and positively related with leukocyte counts after adjusting for age, sex, BMI, SBP, total cholesterol, triglyceride, HDL-cholesterol, current smoking, alcohol ingestion, physical activity, and diabetes mellitus. Although the R 2 value of the regression analysis was relatively low, the R 2 value of the full model (adjusting for all variables including CEA) was significantly F I G U R E 1 Leukocyte counts according to serum CEA tertiles. CEA: carcinoembryonic antigen. T1; CEA ≤1.1, T2: 1.1 < CEA ≤1.9, T3: 1.9 < CEA ≤10. Mean and standard error (indicated with error bars). *P <.001; calculated by Bonferroni post-hoc test.
a P-values were calculated using analysis of covariance (ANCOVA) after adjusting for age and sex.
b P-value were calculated using analysis of covariance (ANCOVA) after age, sex, BMI, SBP, total cholesterol, triglyceride, HDL-cholesterol, cigarette smoking, physical activity and diabetes mellitus higher than the R 2 value of the null model (adjusting for all variables excluding CEA).
Our results support the possibility that serum CEA levels are closely related with subclinical low-grade inflammation. In addition,
we believe that our findings may suggest a possible mechanism regarding the association between serum CEA levels and cardiometabolic diseases. Specifically, although elevated serum CEA levels have long been regarded as a marker of several neoplastic conditions, they may also be modestly elevated in several non-neoplastic conditions. [6] [7] [8] Of these, aging and cigarette smoking appear to be major determinants of elevated CEA levels. Touitou et al. 2 reported that elderly subjects in apparent good health have elevated CEA levels, while
Fukuda et al. 3 showed that serum CEA levels are higher in male smokers (3.11 ng/mL) than in male non-smokers (2.14 ng/mL). More recent evidence indicates that elevated serum CEA levels are also related to metabolic syndrome, non-alcoholic fatty liver disease, atherosclerosis, and arterial stiffness, which are conditions closely linked to chronic low-grade inflammation. Lee et al. 10 reported that serum CEA is positively associated with metabolic syndrome in female Korean nonsmokers. From the same cohort of 200 healthy Korean adults, CEA was shown to be positively associated with non-alcoholic fatty liver disease. 19 Likewise, Esteghamati et al. 20 showed that metabolic syndrome and type 2 diabetes are more prevalent in subjects with high CEA levels. In 4181 Japanese men aged 21-89 years, serum CEA was independently associated with carotid atherosclerosis. 9 In addition, Bae et al. 21 reported that CEA levels are related to arterial stiffness 30 and one study has demonstrated that antisense IGF-1 modulated the expression of CEA in human cells. 31 Our study has some limitations. First, because of the nature of this cross-sectional study, we were unable to establish a causal relationship between CEA levels and leukocyte counts. Second, only one measurement of leukocyte levels was performed, making it difficult to determine whether the increased leukocyte count was reflective of acute inflammation or chronic inflammation. To reduce these errors, we excluded subjects with leukocyte counts <3000 cells/μL or >10 000 cells/μL. Third, because the study subjects were volunteers who received their physical examinations in a single hospital and appeared to be slightly healthier than most community-based cohorts, the study population may not represent the general population of Korea. Therefore, the study may have been affected by selection bias.
Despite this weakness, this is the first study to identify a positive association between CEA and leukocyte counts. We can consider the non-malignant condition related to chronic inflammation in interpreting modestly increased serum CEA level.
| CONCLUSIONS
We identified a significant association between serum CEA and leukocyte count in the general Korean population. Our findings suggest that serum CEA may be a meaningful marker of chronic low-grade inflammation in clinical practice. Our results also indicate that slightly elevated levels of serum CEA may be not an epiphenomenon. 
